---
title: "Multi-omics prediction of hypertension using proteomic, metabolomic scores and blood pressure PRS"
id: "medrxiv-17-multi-omics-models-for-hypertension-prediction-using-blood-pressure-prs-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-multi-omics-models-for-hypertension-prediction-using-blood-pressure-prs-and"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.13.26368055v1?rss=1"
published_at: "2026-11-16T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Multi-omics prediction of hypertension using proteomic, metabolomic scores and blood pressure PRS
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-multi-omics-models-for-hypertension-prediction-using-blood-pressure-prs-and
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.13.26368055v1?rss=1)
- **Published At:** 2026-11-16T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators developed proteomic (ProtS) and metabolomic (MetS) scores for systolic and diastolic **blood pressure** and for **hypertension** using Elastic Net in the Multi-Ethnic Study of Atherosclerosis (MESA). - They combined ProtS and MetS with previously developed **polygenic risk scores (PRS)** in five incremental XGBoost models, and performed external validation in the Jackson Heart Study (JHS). - Transfer learning (leaf-weight refreshing) was applied to adapt MESA-derived models to JHS; this procedure improved calibration in JHS while largely preserving discrimination. - In MESA, adding omics scores raised model AUC from 0.63 (clinical baseline) to 0.72 for the combined model; measured SBP and DBP further elevated discrimination (PRS+BP AUC 0.80 in MESA). - In JHS, **ProtS** achieved the highest external AUC (0.68) and showed the smallest cross-cohort performance decline versus **MetS** and **PRS**; baseline+BP AUC in JHS reached 0.74. - Among JHS participants with normal baseline BP, **ProtS** provided the strongest discrimination among models without measured BP (AUC 0.62); PRS+BP reached AUC 0.69 in that subgroup. - Mendelian randomization and colocalization implicated 77 proteins linked to BP traits or hypertension, spanning vascular, inflammatory, renal, and natriuretic pathways. - The study team observed that measured **blood pressure** remained the single strongest predictor of incident hypertension; proteomic and genetic scores supplied complementary biological signal, particularly before clinical BP elevation is detectable. - The source did not report detailed protein or metabolite effect sizes within this summary, nor full methodological hyperparameters for Elastic Net or XGBoost tuning in the abstract; those details may be in the full text or supplement.
## Clinical Analysis & Structured Key Points
Multi-omics models for hypertension prediction using blood pressure PRS and omics scores | medRxiv Skip to main content Multi-omics models for hypertension prediction using blood pressure PRS and omics scores Ziqing Wang , Yana Hrytsenko , Sivan Almogy , Brian W Spitzer , Yogesh Purushotham , Kent Taylor , Henry J. J. Lin , Usman A. Tahir , View ORCID Profile Laura M. Raffield , Steve Rich , Jerome Rotter , Zsu Zsu Chen , View ORCID Profile Tamar Sofer doi: https://doi.org/10.64898/2026.11.13.26368055 Ziqing Wang 1 BIDMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: zwang14{at}bidmc.harvard.edu Yana Hrytsenko 2 Beth Israel Deaconess Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sivan Almogy 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Brian W Spitzer 2 Beth Israel Deaconess Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yogesh Purushotham 2 Beth Israel Deaconess Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kent Taylor 4 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Henry J. J. Lin 4 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Usman A. Tahir 2 Beth Israel Deaconess Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Laura M. Raffield 5 University of North Carolina; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Laura M. Raffield Steve Rich 6 Virginia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jerome Rotter 4 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Zsu Zsu Chen 1 BIDMC; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tamar Sofer 2 Beth Israel Deaconess Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Tamar Sofer Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Hypertension is a major modifiable risk factor for cardiovascular disease, yet the relative contributions of proteomic (ProtS), metabolomic (MetS), and polygenic risk scores (PRS) to incident hypertension risk remain incompletely characterized. Methods: We developed ProtS and MetS for systolic (SBP) and diastolic blood pressure (DBP), and hypertension using Elastic Net regression in the Multi-Ethnic Study of Atherosclerosis (MESA). We incorporated these scores with previously developed BP PRSs into 5 incremental XGBoost models, with external validation in the Jackson Heart Study (JHS). We further applied transfer learning to adapt the MESA-derived models to JHS. Elastic Net selected proteins were prioritized using Mendelian randomization, colocalization, and functional analyses. Results: In MESA, model discrimination improved with the addition of omics scores, with the combined model achieving an area under the curve (AUC) of 0.72 compared with 0.63 for the clinical baseline model. In JHS, ProtS showed the highest AUC of 0.68 and the smallest cross-cohort performance decline, compared to MetS and PRS. Incorporating measured SBP and DBP substantially improved discrimination, with the PRS+BP model achieving an AUC of 0.80 in MESA and the baseline+BP model achieving an AUC of 0.74 in JHS. Among JHS participants with normal baseline BP, ProtS provided the strongest discrimination among models without measured BP (AUC = 0.62), while PRS+BP model achieved an AUC of 0.69. Leaf-weight refreshing consistently improved calibration in JHS while preserving discrimination. Mendelian randomization identified 77 proteins associated with BP traits or hypertension, involved in vascular, inflammatory, renal, and natriuretic pathways. Conclusions: ProtS demonstrated superior predictive performance and cross-cohort transferability among the omics modalities evaluated, while measured BP remained the strongest predictors of incident hypertension. Proteomic and genetic information may provide complementary biological signals for identifying individuals at elevated hypertension risk, particularly before clinically elevated BP is detectable. Competing Interest Statement LMR and SSR are consultants for the TOPMed Administrative Coordinating Center (through Westat). Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This work was approved by the Beth Israel Deaconess Medical Center Committee on Clinical Investigations, protocol #2023P000541. All MESA participants provided written informed consent, and the study was approved by the Institutional Review Boards at The Lundquist Institute (formerly Los Angeles BioMedical Research Institute) at Harbor-UCLA Medical Center, University of Washington, Wake Forest School of Medicine, Northwestern University, University of Minnesota, Columbia University, and Johns Hopkins University. The Institutional Review Boards at Jackson State University, Tougaloo College, and the University of Mississippi Medical Center approved the original study protocol, and all participants provided written informed consent. Ongoing IRB review for study activities is through the University of Mississippi Medical Center and Wake Forest University Health Sciences. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability TOPMed freeze 10 WGS, and phenotype data are available by application to dbGaP according to the study specific accession: JHS: phs000964, MESA: phs001211. MESA phenotype data are available from dbGaP according to the MESA accession: MESA: phs000209. Funder Information Declared NIH Common Fund, https://ror.org/001d55x84 , R01HL188729 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted November 16, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Multi-omics models for hypertension prediction using blood pressure PRS and omics scores Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Multi-omics models for hypertension prediction using blood pressure PRS and omics scores Ziqing Wang , Yana Hrytsenko , Sivan Almogy , Brian W Spitzer , Yogesh Purushotham , Kent Taylor , Henry J. J. Lin , Usman A. Tahir , Laura M. Raffield , Steve Rich , Jerome Rotter , Zsu Zsu Chen , Tamar Sofer medRxiv 2026.11.13.26368055; doi: https://doi.org/10.64898/2026.11.13.26368055 Share This Article: Copy Citation Tools Multi-omics models for hypertension prediction using blood pressure PRS and omics scores Ziqing Wang , Yana Hrytsenko , Sivan Almogy , Brian W Spitzer , Yogesh Purushotham , Kent Taylor , Henry J. J. Lin , Usman A. Tahir , Laura M. Raffield , Steve Rich , Jerome Rotter , Zsu Zsu Chen , Tamar Sofer medRxiv 2026.11.13.26368055; doi: https://doi.org/10.64898/2026.11.13.26368055 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (642) Allergy and Immunology (923) Anesthesia (355) Cardiovascular Medicine (5038) Dentistry and Oral Medicine (496) Dermatology (430) Emergency Medicine (680) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1701) Epidemiology (16322) Forensic Medicine (36) Gastroenterology (1243) Genetic and Genomic Medicine (7310) Geriatric Medicine (758) Health Economics (1098) Health Informatics (5325) Health Policy (1477) Health Systems and Quality Improvement (1842) Hematology (599) HIV/AIDS (1386) Infectious Diseases (except HIV/AIDS) (16517) Intensive Care and Critical Care Medicine (1205) Medical Education (701) Medical Ethics (157) Nephrology (755) Neurology (7638) Nursing (380) Nutrition (1137) Obstetrics and Gynecology (1300) Occupational and Environmental Health (1044) Oncology (3755) Ophthalmology (1101) Orthopedics (413) Otolaryngology (470) Pain Medicine (506) Palliative Medicine (144) Pathology (722) Pediatrics (1871) Pharmacology and Therapeutics (758) Primary Care Research (789) Psychiatry and Clinical Psychology (6168) Public and Global Health (10032) Radiology and Imaging (2550) Rehabilitation Medicine and Physical Therapy (1532) Respiratory Medicine (1277) Rheumatology (663) Sexual and Reproductive Health (810) Sports Medicine (601) Surgery (807) Toxicology (109) Transplantation (320) Urology (309)
## Related Clinical Research

- [Smartwatch AI approximates office blood-pressure screening for undiagnosed hypertension](https://medichelpline.com/clinical-feed/nature-0-harnessing-smartwatches-to-spot-undiagnosed-hypertension.md)
- [Sleep Duration and Mortality in US Adults With Heart Disease — NHIS-NDI Cohort Findings](https://medichelpline.com/clinical-feed/plos-one-14-sleep-duration-and-cause-specific-mortality-among-us-adults-with-heart-disease.md)
- [Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort](https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart.md)
- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [Hysterectomy Linked to Higher Risk of Cardiometabolic Factors: Systematic Review & Meta-analysis](https://medichelpline.com/clinical-feed/medrxiv-2-decision-for-hysterectomy-as-a-modifiable-cardiovascular-risk-factor-a.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.